AU-285

N/A

Report date: 2025/06/13 14:51:39
NME

Base Information

Drug NameAU-285
Drug Alias NameAU-285AU2-85
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 8 inhibitors
TargetsCyclin-dependent kinase 8
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAucentra Therapeutics Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAucentra Therapeutics Pty Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A